Literature DB >> 25573488

Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: a prospective cohort study.

Thanachai Panaput1, Bandit Thinkhamrop, Somnuek Domrongkitchaiporn, Dhavee Sirivongs, Laksamon Praderm, Jirasak Anukulanantachai, Chavasak Kanokkantapong, Pakorn Tungkasereerak, Cholatip Pongskul, Sirirat Anutrakulchai, Thathsalang Keobounma, Surapong Narenpitak, Pisith Intarawongchot, Ammrit Suwattanasin, Sajja Tatiyanupanwong, Kannika Niwattayakul.   

Abstract

BACKGROUND/AIMS: We aimed to define the dosing and risk factors for death in patients undergoing twice-weekly hemodialysis.
METHODS: A prospective multi-center cohort study was conducted with one-year observation. Patients treated with twice- or thrice-weekly hemodialysis were identified. Death and first admission were the outcomes. spKt/V was a factor of interest.
RESULTS: We enrolled 504 twice-weekly and 169 thrice-weekly hemodialysis patients. The mean weekly values of spKt/V in the two groups were 3.4 and 5.1. The one-year survival rate and times to hospitalization were similar in both groups. The hazard ratios for death in higher spKt/V quartile was not associated with lower mortality, p = 0.70. The four significant predictors for death were serum albumin, HR = 2.6, current smoking, HR = 19.3, age, HR = 1.1, and the Index of Coexistent Disease [ICED], HR = 1.9.
CONCLUSION: The effect of spKt/V on short-term mortality was not obvious in twice-weekly dialysis patients. Attention should be paid to patients who smoke, have hypoalbuminemia, are elderly, or have a high ICED.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25573488     DOI: 10.1159/000368885

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  8 in total

Review 1.  Twice-Weekly Hemodialysis in China: Can It Be A Better Option for Initiation or Maintenance Dialysis Therapy?

Authors:  Yucheng Yan; Sylvia Ramirez; Shuchi Anand; Jiaqi Qian; Li Zuo
Journal:  Semin Dial       Date:  2017-03-26       Impact factor: 3.455

2.  Renal Association Clinical Practice Guideline on Haemodialysis.

Authors:  Damien Ashby; Natalie Borman; James Burton; Richard Corbett; Andrew Davenport; Ken Farrington; Katey Flowers; James Fotheringham; R N Andrea Fox; Gail Franklin; Claire Gardiner; R N Martin Gerrish; Sharlene Greenwood; Daljit Hothi; Abdul Khares; Pelagia Koufaki; Jeremy Levy; Elizabeth Lindley; Jamie Macdonald; Bruno Mafrici; Andrew Mooney; James Tattersall; Kay Tyerman; Enric Villar; Martin Wilkie
Journal:  BMC Nephrol       Date:  2019-10-17       Impact factor: 2.388

Review 3.  Incremental Hemodialysis: What We Know so Far.

Authors:  Vivek Soi; Mark D Faber; Ritika Paul
Journal:  Int J Nephrol Renovasc Dis       Date:  2022-04-29

4.  Incremental dialysis in ESRD: systematic review and meta-analysis.

Authors:  Carlo Garofalo; Silvio Borrelli; Toni De Stefano; Michele Provenzano; Michele Andreucci; Gianfranca Cabiddu; Vincenzo La Milia; Valerio Vizzardi; Massimo Sandrini; Giovanni Cancarini; Adamasco Cupisti; Vincenzo Bellizzi; Roberto Russo; Paolo Chiodini; Roberto Minutolo; Giuseppe Conte; Luca De Nicola
Journal:  J Nephrol       Date:  2019-01-02       Impact factor: 3.902

5.  B-type natriuretic peptide levels and volume status in twice-weekly hemodialysis patients.

Authors:  Nina Fang; Miaolin Che; Ling Shi; Zanzhe Yu; Zhaohui Ni; Wei Fang; Huihua Pang; Leyi Gu; Xinghui Lin
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

Review 6.  Role of Myeloperoxidase in Patients with Chronic Kidney Disease.

Authors:  Bojana Kisic; Dijana Miric; Ilija Dragojevic; Julijana Rasic; Ljiljana Popovic
Journal:  Oxid Med Cell Longev       Date:  2016-04-03       Impact factor: 6.543

7.  Incremental short daily home hemodialysis: a case series.

Authors:  Stephanie M Toth-Manikowski; Surekha Mullangi; Seungyoung Hwang; Tariq Shafi
Journal:  BMC Nephrol       Date:  2017-07-05       Impact factor: 2.388

8.  Impact of incremental versus conventional initiation of haemodialysis on residual kidney function: study protocol for a multicentre feasibility randomised controlled trial.

Authors:  Raja Mohammed Kaja Kamal; Ken Farrington; David Wellsted; Sivakumar Sridharan; Bassam Alchi; James Burton; Andrew Davenport; Enric Vilar
Journal:  BMJ Open       Date:  2020-08-13       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.